Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors
The NORDIC SUN trial is currently investigating the effectiveness and timing of cytoreductive nephrectomy in patients with newly diagnosed synchronous metastatic renal cell carcinoma (mRCC) being treated with IO-treatment regimens.